Use of LUPKYNIS was safe and well tolerated in patients for up to three years of treatment, with no new safety signals In AURORA 2, long-term treatment with LUPKYNIS led to a clinically relevant preservation of kidney function in LN patients A pooled analysis from the AURA-LV and AURORA 1 studies, also presented at ERA, … [Read more…]
Members serve as community ambassadors in the communities Eastern serves BOSTON–(BUSINESS WIRE)–Eastern Bank is pleased to announce the election of five local community and business leaders to its Board of Advisors and Board of Ambassadors. The newly elected Advisors are: – Carolina Alarco, Founder and Principal, Bio Strategy Advisors LLC, and – Michael A. Curry, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Anxiety Drugs Market Research Report by Type (Generic Drugs and Patent Medicine), Application, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Anxiety Drugs Market size was estimated at USD 3,023.13 million in 2021, USD 3,448.71 million in 2022, and … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Social Anxiety Disorder (SAD) – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This “Social Anxiety Disorder (SAD) – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Social Anxiety Disorder (SAD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Acute Social Anxiety Disorder- Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This “Acute Social Anxiety Disorder – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Acute Social Anxiety Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “General Anxiety Disorder (GAD) – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This “General Anxiety Disorder (GAD) – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted General Anxiety Disorder (GAD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Anxiety Disorders pipeline landscape. The report provides comprehensive information on the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Social Anxiety Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. Social Anxiety Disorder (SAD/Social Phobia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Social Anxiety Disorder (SAD/Social Phobia) pipeline landscape. … [Read more…]
uPerform achieves APN Advanced Tier Member designation for its expertise with AWS ELKRIDGE, Md.–(BUSINESS WIRE)–#uPerform—uPerform the market-leading just-in-time training and support platform, announces that it successfully achieved Amazon Web Services Partner Network (APN) Advanced Tier Member status. Amazon Web Services (AWS) recognizes its APN Advanced Tier members due to their knowledge, experience, and customer success … [Read more…]
RALEIGH, N.C.–(BUSINESS WIRE)–MobileSmith (OTCBB: MOST), a leading provider of cutting-edge mobile software solutions, announces the appointment of Christine Havlin as their Chief Marketing Officer. “As MSH adds more clinical functionality to our platform it became a strategic imperative to add a marketing leader with deep provider experience. We are thrilled to add Christine to lead … [Read more…]
